Exploring Maternal Mental Health and Neonatal Risks in SSRI Study – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
” In a large national cohort from Finland (over 1.2 million births), SSRI exposure was linked to:
- Lower risks of very preterm birth and low birth weight
- Higher risk of neonatal adaptation symptoms (eg, breathing problems, low 5-minute Apgar, neonatal care)
- Persistent increased risk of gestational diabetes
Takeaway: SSRI use during pregnancy has complex, independent effects — balancing maternal mental health benefits with neonatal adaptation considerations.
Read the full text to learn more.”
Proceed to the video attached to the post.
Title: SSRI use during pregnancy and maternal depression – a nationwide birth cohort study on risks to the mother and the newborn
Authors: Heli Malm, Alan S. Brown, Keely Cheslack-Postava, Mika Gissler, David Gyllenberg, Emmi Heinonen, Susanna Hinkka-Yli-Salomäki, Ian W. McKeague, Aleksi Tornio, Subina Upadhyaya, Andre Sourander
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 13, 2026, 08:40Antonio La Marca: April 15 Webinar to Focus on Thermal Ablation for Fibroids and Adenomyosis
-
Apr 13, 2026, 08:34Raising Awareness of Endometriosis at Paris Women’s Health Forum 2026 – Filière Endométriose Île-de-France
-
Apr 12, 2026, 07:31Antonio La Marca: Upcoming Webinar to Explore Uterine Artery Embolization and Thermal Ablation of Fibroids
-
Apr 12, 2026, 07:28South Carolina, IVF is Under Threat Again! – RESOLVE
-
Apr 12, 2026, 07:18New Series Explores Paths Into Reproductive Medicine Leadership – ASRM
-
Apr 12, 2026, 07:11Latest Episode of RCOG Surgical Skills Project – RCOG
-
Apr 12, 2026, 07:03Christopher Robinson: Uterine Artery Injury During Cesarean Deliveries
-
Apr 12, 2026, 06:58Robert Brown: Overview of Maternal Mortality
-
Apr 12, 2026, 06:54Tanya Freirich: Experts Exchange Lupus Pregnancy and Nutrition Tips